As the original equipment manufacturer of the aircraft, Textron Aviation can offer the OEM-certified upgrade of the Cessna Citation CJ1 avionics that maintains the system integrity as originally ...

Clay’s revenue is on track to more than triple this year, and its more than 10,000 customers include leading AI companies like OpenAI, Anthropic, and Cursor, as well as fast-growing companies like ...

Eleven Music users can effortlessly generate their ideal track, in any genre or style, with or without vocals, in numerous languages – and in a matter of minutes. Generated tracks can be used for ...

Andersen Consulting enhances its digital transformation and cybersecurity capabilities with the addition of collaborating firm Systematix, a leading technology consultancy known for delivering ...

MSCI Inc. (NYSE: MSCI) has launched two new data and analytics solutions, Private Asset and Deal Metrics and Real Capital Analytics (RCA) Funds, designed to provide General Partners (GPs) with deeper ...

TTI delivered a strong first half performance, growing sales 7.5% in local currency to US$7.8 billion and net profit 14.2% to US$628 million. Our Flagship MILWAUKEE business extended its dominant ...

Brian Longe, chief executive officer of G2RS, will serve as CEO of the combined company. EverC CEO Ariel Tiger will serve as an adviser through the end of the year to support a smooth transition. The ...

Bentley Systems, Incorporated (Nasdaq: BSY), the infrastructure engineering software company, today announced the finalists ...

Regnology, a leading software provider with a focus on regulatory reporting solutions, today announced it has entered into a definitive agreement to acquire Wolters Kluwer’s Finance, Risk & Regulatory ...

Omdia forecasts that the market for cloud-enabled operational solutions for games will grow to $20.9bn by 2029—equivalent to ...

Concept Medical Inc., a global pioneer in drug-delivery technologies, announced the enrollment of the first patient in the ...

VX-993 was generally safe and well tolerated at all doses studied in the trial. The overall incidence of adverse events on VX-993 was similar to placebo. The majority of the AEs were mild or moderate ...